INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

81,434 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
UM
Uotani MasahikoDirector
ACNAccenture plc
Tax withholding
F$672
3 sh
Feb 13, 2026Feb 17, 2026
Page 1543 of 2036
← PrevNext →
traded Feb 13, 2026
+4d
SEC Form 4

Evidence

9
BL
Boyd Tiffanie L.EVP - Chief People Officer
MCDMCDONALDS CORP
Option exercise
M—
89 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
SB
Shah Mitesh BansilalSVP and CHRO
VMCVulcan Materials CO
Option exercise
M—
1,684 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Option exercise
M—
4,015 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Grant or award
A—
18.1K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
NJ
Nason JenniferDirector
ACNAccenture plc
Tax withholding
F$448
2 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
GJ
Gough William JohnVP, Controller & CAO
NEENEXTERA ENERGY INC
Tax withholding
F$9,474
101 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

9
PY
Park Angie YChief Financial Officer
ACNAccenture plc
Grant or award
A—
32 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Option exercise
M—
1,879 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
KY
Kim YongsooSee Remarks
WBTNWEBTOON Entertainment Inc.
Tax withholding
F$50K
4,679 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

9
CA
Carlisle Mary AndrewsSVP and CFO
VMCVulcan Materials CO
Option exercise
M—
5,330 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
JC
Jope Alan C.Director
ACNAccenture plc
Grant or award
A—
8 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Option exercise
M—
409 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Option exercise
M—
2,693 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MG
McDonald GillianEVP, Global Rest. Exp. Ofc.
MCDMCDONALDS CORP
Option exercise
M—
161 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
PY
Park Angie YChief Financial Officer
ACNAccenture plc
Tax withholding
F$1,569
7 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
5,479 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MG
McDonald GillianEVP, Global Rest. Exp. Ofc.
MCDMCDONALDS CORP
Option exercise
M—
296 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BF
Baumgartner FlorianEVP and CEO, Vista
CMPRCIMPRESS plc
Option exercise
M—
1,303 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

9
UM
Uotani MasahikoDirector
ACNAccenture plc
Grant or award
A—
5 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
RR
Riel RyanSr. Executive Vice President
EGBNEAGLE BANCORP INC
Tax withholding
F$26K
980 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,359 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BL
Boyd Tiffanie L.EVP - Chief People Officer
MCDMCDONALDS CORP
Option exercise
M—
70 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Option exercise
M—
30 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BM
Brudermueller MartinDirector
ACNAccenture plc
Tax withholding
F$672
3 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
NJ
Nason JenniferDirector
ACNAccenture plc
Grant or award
A—
5 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MR
McPherson Danny REVP - Technology & CSO
VRSNVERISIGN INC/CA
Tax withholding
F$35K
159 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Grant or award
A—
1,069 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Option exercise
M—
215 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BP
Bhalla Narinder PalChief Medical Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
49.5K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MG
McDonald GillianEVP, Global Rest. Exp. Ofc.
MCDMCDONALDS CORP
Grant or award
A—
30.1K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
SR
Sekido RyojiCo-CEO Asia Pacific
ACNAccenture plc
Grant or award
A—
18 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BL
Boyd Tiffanie L.EVP - Chief People Officer
MCDMCDONALDS CORP
Option exercise
M—
70 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

8
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
18.8K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

8
DK
Davis KristaSVP, CHIEF HR OFFICER
ANIPANI PHARMACEUTICALS INC
Tax withholding
F$100K
1,290 sh
Feb 14, 2026Feb 17, 2026
traded Feb 14, 2026
+3dSEC Form 4

Evidence

8
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
112.5K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

8
PA
Patel AnishCHIEF OPERATING OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
120.0K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

8
PA
Patel AnishCHIEF OPERATING OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
20.0K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

5
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise
M—
250 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

5
MJ
Malcolm JanDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$24K
50 sh
Feb 17, 2026Feb 17, 2026
traded Feb 17, 2026
+0dSEC Form 4

Evidence